logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-37. Amphetamines and ecstasy clients entering drug treatment, 2009 or most recent year available [see all tables in this series...]

Part (v) Inpatient clients by secondary drug and primary drug

Secondary drugAmphetaminesMDMA and other derivatives
Cannabis 128337
Stimulants (other than cocaine)12015
Hypnotics and sedatives43111
Volatile inhalants241
Other substances 633
Total number of citations3165121


 Clients may report one primary drug, but more than one secondary drug 

 Countries providing data are: BE, BG, CZ, DK, IE, GR, FR, LU, HU, NL, AT, RO, SK, FI, SE, UK, HR, TR. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also 'General notes for interpreting data’ on the Explanatory notes and help page


 Reitox national reports 2010 — Table TDI by centre type.  

(see the help page for information about formats etc.)

Page last updated: Thursday, 30 June 2011